Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18574
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKei, A. A.en
dc.contributor.authorFlorentin, M.en
dc.contributor.authorMikhailidis, D. P.en
dc.contributor.authorElisaf, M. S.en
dc.contributor.authorLiberopoulos, E. N.en
dc.date.accessioned2015-11-24T18:53:31Z-
dc.date.available2015-11-24T18:53:31Z-
dc.identifier.issn1938-2723-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18574-
dc.rightsDefault Licence-
dc.subjectAnimalsen
dc.subjectDrug Hypersensitivity/etiologyen
dc.subjectHumansen
dc.subjectPlatelet Aggregation Inhibitors/*adverse effects/*classification/*therapeutic useen
dc.subjectThrombosis/drug therapy/mortalityen
dc.titleReview: Antiplatelet drugs: what comes next?en
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1177/1076029610385222-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/21078606-
heal.identifier.secondaryhttp://cat.sagepub.com/content/17/1/9.full.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2011-
heal.abstractAntiplatelet drugs are important components in the management of atherothrombotic vascular disease. However, several limitations restrict the safety and efficacy of current antiplatelet therapy in clinical practice. Interpatient variability and resistance to aspirin and/or clopidogrel has spurred efforts for the development of novel agents. Indeed, several antiplatelet drugs are at various stages of evaluation; those at advanced stage of development are the focus of this review.en
heal.journalNameClin Appl Thromb Hemosten
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Kei-2011-Review_ Antiplatelet.pdf346.21 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons